Adrenal insufficiency and diabetes are linked through several distinct but overlapping pathways: shared autoimmune origins, the direct role cortisol plays in blood sugar regulation, and the tricky medication balancing act required when both conditions coexist. The connection is strongest between Addison’s disease (autoimmune primary adrenal insufficiency) and type 1 diabetes, where the same immune system attack can target both the adrenal glands and the insulin-producing cells of the pancreas. But the relationship extends beyond autoimmunity into everyday glucose management, emergency scenarios, and even diagnostic technology.
How Cortisol Shapes Blood Sugar
Cortisol, the main hormone produced by the adrenal glands, is one of the body’s key tools for keeping blood sugar from dropping too low. When blood glucose starts falling, cortisol kicks the liver into producing more glucose while simultaneously dialing back how much glucose muscles and other tissues absorb. In a classic study that isolated the effect of cortisol during induced hypoglycemia, blocking the normal cortisol rise caused the liver to produce roughly 22% less glucose and tissues to consume about 15% more, resulting in significantly deeper drops in blood sugar despite the body’s attempts to compensate with adrenaline.1PubMed. Contribution of cortisol to glucose counterregulation in humans Cortisol also promotes the breakdown of fat for energy, providing an alternative fuel source when glucose is scarce.
When the adrenal glands cannot produce enough cortisol, this safety net disappears. Neonates with adrenal insufficiency are especially vulnerable, but older children and adults remain at real risk of hypoglycemia as well.2PubMed Central. Hypoglycaemia in adrenal insufficiency For someone without diabetes, a missed cortisol response might cause mild shakiness or fatigue. For someone already on insulin, losing that cortisol buffer can mean severe, recurrent lows that are hard to explain with diet or dosing changes alone.
The Autoimmune Thread Connecting Addison’s Disease and Type 1 Diabetes
The most direct biological link between adrenal insufficiency and diabetes is autoimmunity. In autoimmune polyglandular syndrome type 2 (APS-2), the immune system attacks multiple endocrine glands. The classic combination involves the adrenal glands and the thyroid (called Schmidt syndrome), but the adrenal glands and the insulin-producing beta cells of the pancreas can also be targeted together (called Carpenter syndrome).3Journal of Nephrology & Renal Therapy. Debut of Polyglandular Autoimmune Syndrome Type 2 (Schmidt Syndrome) in a Patient with Chronic Kidney Disease of Unknown Etiology in Peritoneal Dialysis APS-2 is the most common of the polyglandular syndromes, affecting women about three times as often as men, and typically appears between a person’s thirties and forties.
The genetic roots of this shared vulnerability lie in a region of chromosome 6 known as the HLA complex, which helps the immune system distinguish the body’s own tissues from invaders. Both Addison’s disease, type 1 diabetes, and celiac disease are all associated with a variant called HLA-DR3, though additional genes in the same chromosomal neighborhood contribute to the risk for each condition individually.4PubMed Central. Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison’s disease This means carrying HLA-DR3 does not guarantee you will develop any one of these diseases, but it does increase the odds that if one autoimmune condition shows up, others may follow. Case reports illustrate this cascading pattern: a patient presenting with an adrenal crisis may also test positive for antibodies against pancreatic beta cells, suggesting type 1 diabetes could emerge later.5Annals of Medicine and Surgery. Autoimmune polyglandular syndrome type 2: A case report
Population-level data confirms that the overlap is not rare among people who already have type 1 diabetes. A Swedish matched-cohort study found the prevalence of Addison’s disease among people with type 1 diabetes was roughly 3,410 per million, compared with just 208 per million in people without type 1 diabetes.6European Journal of Endocrinology. Incidence, prevalence and seasonal onset variation of Addison’s disease among persons with type 1 diabetes mellitus: nationwide, matched cohort studies That is more than a 16-fold difference, and it makes a strong case for clinicians to stay alert for adrenal problems in their type 1 diabetes patients.
Screening People With Type 1 Diabetes for Adrenal Problems
Given the shared autoimmune susceptibility, researchers have explored whether routine antibody screening could catch Addison’s disease early in people with type 1 diabetes. One large screening effort tested over 2,600 individuals with type 1 diabetes for 21-hydroxylase autoantibodies, which target a key enzyme in cortisol production. About 1.4% tested positive. Among those positive individuals who underwent further hormonal evaluation, six were diagnosed with Addison’s disease, including one who was caught only after follow-up lasting nearly three years.7PubMed. Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison’s disease in a high-risk population
A 1.4% antibody positivity rate might sound small, but it is far higher than the general population rate, and those positive individuals carry a meaningful risk of progressing to clinical disease. The challenge is that adrenal insufficiency often develops slowly and its early symptoms, like fatigue, weight loss, and dizziness, can easily be blamed on poorly managed diabetes. By the time hyperpigmentation of the skin or a frank adrenal crisis occurs, the disease has usually been present for months or years.
Unexplained Hypoglycemia and the Role of Continuous Glucose Monitors
For someone with type 1 diabetes who is already on insulin, developing adrenal insufficiency often shows up as a puzzling pattern: blood sugar keeps dropping even though nothing about diet, exercise, or insulin dosing has changed. The insulin requirement starts falling, sometimes dramatically. If a clinician is not thinking about cortisol, these episodes get attributed to other causes or just labeled as unexplained hypoglycemia.
Continuous glucose monitors (CGMs) have turned out to be unexpectedly useful for catching this pattern. In one published case, an adolescent girl with type 1 diabetes was diagnosed with latent Addison’s disease based on a recurring hypoglycemic trend at dawn that her CGM detected. The persistent pattern of unexplained lows, especially the decreased insulin requirement, raised suspicion of adrenal insufficiency and prompted the testing that confirmed Addison’s disease while it was still clinically mild.8PubMed Central. Type 1 Diabetes and Addison’s Disease: When the Diagnosis Is Suggested by the Continuous Glucose Monitoring System A separate study demonstrated that CGMs can also detect nocturnal hypoglycemia in people with primary adrenal insufficiency who are already on cortisol replacement therapy, helping fine-tune dosing to prevent dangerous nighttime lows.9PubMed Central. Nocturnal Hypoglycemia Identified by a Continuous Glucose Monitoring System in Patients with Primary Adrenal Insufficiency (Addison’s Disease)
More advanced insulin pump systems can complicate the diagnostic picture in an interesting way. Hybrid closed-loop systems automatically reduce insulin delivery when glucose trends downward. In one case involving the MiniMed 780G, the pump’s algorithm adapted so effectively to the patient’s falling cortisol levels that recorded hypoglycemia was kept very low in the period before a full adrenal crisis hit.10JCEM Case Reports. Onset of Addison Disease in a Patient Using the Advanced Hybrid Closed-Loop MiniMed 780G: Diagnostic Challenges In other words, the very technology designed to protect against lows can mask the warning signs that something more serious is going wrong. Clinicians managing patients on automated insulin systems need to look beyond glucose readings and pay attention to trends in total daily insulin dose, which may quietly slide downward as cortisol production fails.
Adjusting Insulin When Cortisol Replacement Enters the Picture
Once adrenal insufficiency is diagnosed in someone with type 1 diabetes, treatment requires replacing cortisol, usually with oral hydrocortisone taken two or three times a day. The problem is that current replacement regimens do not perfectly mimic the body’s natural cortisol rhythm, which peaks in the early morning and tapers through the day. This mismatch directly affects insulin requirements: too much cortisol replacement pushes blood sugar up; too little lets it crash.11European Journal of Endocrinology. Altered insulin requirement in patients with type 1 diabetes and primary adrenal insufficiency receiving standard glucocorticoid replacement therapy
Research into modified-release hydrocortisone formulations is partly motivated by this problem. In one randomized trial, a once-daily modified-release version of hydrocortisone led to meaningful body weight reduction compared with standard divided-dose therapy over 24 weeks, a difference of about 4 kilograms between groups.12Lancet Diabetes Endocrinol. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM) Weight gain is a well-known side effect of cortisol replacement and a metabolic concern for anyone also managing diabetes, so formulations that more closely replicate the natural cortisol curve could improve outcomes on both fronts. For patients navigating both conditions, the day-to-day reality involves constant calibration: adjusting insulin doses around hydrocortisone timing, accounting for sick days when cortisol needs spike, and watching for the early-morning blood sugar surges that peak-dose hydrocortisone can trigger.
Glucocorticoids Pushing Blood Sugar in the Other Direction
The adrenal-diabetes connection also runs the opposite way. Glucocorticoid medications, synthetic versions of cortisol used to treat inflammation, allergies, and autoimmune diseases, are a well-known cause of high blood sugar. They can worsen glucose control in people who already have diabetes, unmask previously undiagnosed diabetes, or cause a form called glucocorticoid-induced diabetes in people who had no prior glucose problems.13PubMed Central. Management of Glucocorticoid-Induced Hyperglycemia
This means the same category of hormone sits at the center of both too-low and too-high blood sugar, depending on the direction of the imbalance. Adrenal insufficiency (too little cortisol) pulls glucose down. Glucocorticoid therapy or cortisol-producing tumors (too much cortisol) push glucose up. For patients and clinicians, recognizing this two-way street is essential. A person who needs steroids for a flare of another autoimmune condition while also managing type 1 diabetes may need to temporarily increase their insulin doses. Conversely, stopping steroid therapy abruptly can cause both an adrenal crisis and dangerous hypoglycemia.
When Adrenal Crisis and Diabetic Ketoacidosis Collide
Both conditions have their own life-threatening emergencies, and occasionally they strike at the same time. Diabetic ketoacidosis (DKA), a dangerous buildup of acids caused by inadequate insulin, creates enormous physiological stress. In someone with underlying but undiagnosed adrenal insufficiency, that stress can be the trigger that tips them into a full adrenal crisis. A published case described a 32-year-old man whose first sign of Addison’s disease was an acute adrenal crisis that emerged in the setting of DKA.14Endocrinology and Metabolism. A Case of Type II Autoimmune Polyglandular Syndrome: Acute adrenal crisis presented as the first manifestation of Addison’s disease in a patient with diabetic ketoacidosis and hypgonadism
The combination is dangerous because the two crises pull treatment in opposite directions. DKA demands aggressive fluid resuscitation and insulin. Adrenal crisis demands immediate IV hydrocortisone. Without suspecting both conditions, the adrenal crisis can go untreated, and the low blood pressure and electrolyte disturbances it causes may not respond as expected to standard DKA treatment. Emergency physicians sometimes pick up adrenal insufficiency in hypoglycemic patients by noticing low potassium, low blood pressure, or elevated eosinophil counts, clues that help distinguish adrenal-related hypoglycemia from other causes.15Journal of the Endocrine Society. Frequency of Adrenal Insufficiency in Patients With Hypoglycemia in an Emergency Department: A Cross-sectional Study
Secondary Adrenal Insufficiency and Pituitary Disease
Not all adrenal insufficiency is autoimmune. The pituitary gland, which sits at the base of the brain, produces the hormone ACTH that tells the adrenal glands to make cortisol. When the pituitary is damaged or dysfunctional, the adrenals do not get the signal and cortisol production drops. This “secondary” form of adrenal insufficiency is actually more common than the primary (Addison’s) type. In a study of hypoglycemic emergency department patients found to have adrenal insufficiency, 27 of 32 cases were secondary, all involving isolated ACTH deficiency.15Journal of the Endocrine Society. Frequency of Adrenal Insufficiency in Patients With Hypoglycemia in an Emergency Department: A Cross-sectional Study Two additional cases were tertiary, caused by chronic steroid use suppressing the whole hormonal axis.
For diabetes patients, secondary adrenal insufficiency matters because pituitary problems can affect multiple hormones at once, creating a more complex hormonal picture. And chronic steroid use for conditions like asthma, inflammatory bowel disease, or rheumatoid arthritis is widespread, meaning tertiary adrenal insufficiency from suppressed pituitary function is something a lot of people are unknowingly at risk for.
Steroid Replacement Unmasking Diabetes Insipidus
There is an unexpected twist involving a completely different type of “diabetes.” Diabetes insipidus, which involves excessive thirst and urination due to problems with the water-regulating hormone vasopressin, has nothing to do with blood sugar. But it can be hidden by adrenal insufficiency. When cortisol levels are low, the body ramps up vasopressin release, which increases water retention in the kidneys. This extra vasopressin can mask an underlying vasopressin deficiency. Once cortisol replacement begins, the artificial suppression lifts, and diabetes insipidus symptoms can suddenly appear or dramatically worsen.16CMAJ. Central diabetes insipidus emerging after steroid replacement in pituitary apoplexy17Journal of the ASEAN Federation of Endocrine Societies. Worsening of Existing Cranial Diabetes Insipidus Symptoms After Commencement of Hydrocortisone
This scenario is most likely in patients with pituitary disease, where both ACTH production and vasopressin production can be compromised. Clinicians starting someone on hydrocortisone replacement after diagnosing secondary adrenal insufficiency should watch for a sudden surge in urine output and thirst, which would signal that diabetes insipidus needs to be treated as well.
Pediatric Cases and Growth Concerns
In children with type 1 diabetes, adrenal insufficiency adds another layer of concern: growth. A case report described an 11-year-old boy with type 1 diabetes whose weight had been tracking normally until age 8, when he was diagnosed with diabetes. Between ages 10 and 11, he developed persistent growth deceleration of both height and weight despite reasonable diabetes control, along with poor school performance and skin darkening. The culprit turned out to be primary adrenal insufficiency.18Journal of the Endocrine Society. Primary Adrenal Insufficiency in a Boy with Type I Diabetes: The Importance of Considering X-linked Adrenoleukodystrophy
Growth deceleration in a child with diabetes is often attributed to the diabetes itself, especially if HbA1c levels are not perfect. But when growth continues to falter despite adequate glucose management, adrenal insufficiency belongs on the differential diagnosis. The skin hyperpigmentation that characterizes Addison’s disease can be a helpful clue in children, though it is easy to overlook if no one is specifically looking for it. In this particular case, the investigation also uncovered X-linked adrenoleukodystrophy, a rare genetic condition that can cause adrenal failure, underscoring that not every case of adrenal insufficiency in a diabetic child is autoimmune in origin.
Adrenal Tumors and Insulin Resistance
The adrenal-diabetes relationship extends beyond cortisol. The adrenal glands also produce catecholamines like adrenaline, and tumors called pheochromocytomas can flood the body with these hormones. Excess catecholamines impair the way cells respond to insulin, driving up blood sugar. A study of patients with pheochromocytomas found that insulin sensitivity improved substantially after the tumors were surgically removed. In patients who had diabetes, the glucose needed to maintain normal blood sugar during a controlled test increased from about 27.5 to 44.6 micromoles per kilogram per minute after surgery, and fasting insulin levels fell significantly.19PubMed. Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma Even in patients without diabetes, insulin sensitivity improved after the adrenal tumors were removed.
Pheochromocytomas are uncommon, but this finding reinforces a broader point: the adrenal glands influence blood sugar through multiple hormones, not just cortisol. Any significant adrenal disease, whether it involves too little cortisol, too much cortisol, or excess catecholamines, has the potential to disrupt glucose metabolism. For someone with unexplained swings in blood sugar control, especially if accompanied by episodes of high blood pressure, rapid heartbeat, or sweating, an adrenal workup may be warranted even if the classic signs of Addison’s disease are absent.